Shaker A Mousa researcher
Mousa, Shaker A.
VIAF ID: 50055511 (Personal)
Permalink: http://viaf.org/viaf/50055511
Preferred Forms
- 100 1 _ ‡a Mousa, Shaker A.
- 100 1 _ ‡a Mousa, Shaker A.
-
-
- 100 1 _ ‡a Mousa, Shaker A.
-
- 100 1 _ ‡a Mousa, Shaker A.
-
- 100 0 _ ‡a Shaker A Mousa ‡c researcher
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
Angiogenesis inhibitors and stimulators : potential therapeutic implications | |
Angiogenesis modulations in health and disease : practical applications of pro-and anti-angiogenesis targets | |
Anti-angiogenesis strategies in cancer therapies | |
Anticoagulants, antiplatelets, and thrombolytics | |
The antiplatelet activity of camel urine | |
Cell adhesion molecules and matrix proteins : role in health and diseases | |
Multifunctional Nanomaterials and Their Applications in Drug Delivery and Cancer Therapy. | |
Nano Ellagic Acid Counteracts Cisplatin-Induced Upregulation in OAT1 and OAT3: A Possible Nephroprotection Mechanism | |
Nano-Targeted Delivery of Toremifene, an Estrogen Receptor-α Blocker in Prostate Cancer. | |
Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising its Anticancer Efficacy in Breast Cancer | |
Nanoformulated Bioactive Compounds Derived from Different Natural Products Combat Pancreatic Cancer Cell Proliferation | |
Nanoparticle delivery of natural products in the prevention and treatment of cancers: current status and future prospects. | |
Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts | |
Nanotechnology-based detection and targeted therapy in cancer: nano-bio paradigms and applications | |
Nanotetrac targets integrin αvβ3 on tumor cells to disorder cell defense pathways and block angiogenesis | |
Natural products for chemopreventive and adjunctive therapy in oncologic disease. | |
NDAT Targets PI3K-Mediated PD-L1 Upregulation to Reduce Proliferation in Gefitinib-Resistant Colorectal Cancer | |
Neurodegenerative Diseases and Cell Reprogramming | |
New Interfaces of Thyroid Hormone Actions With Blood Coagulation and Thrombosis | |
Non-small cell lung cancer: current treatment and future advances | |
Nonthyroidal Illness Syndrome and Thyroid Hormone Actions at Integrin αvβ3. | |
Novel Anti-Alzheimer's Therapeutic Molecules Targeting Amyloid Precursor Protein Processing | |
Novel leptin OB3 peptide-induced signaling and progression in thyroid cancers: Comparison with leptin. | |
Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice. | |
Novel Targeted Nano-Parthenolide Molecule against NF-kB in Acute Myeloid Leukemia | |
Nuclear monomeric integrin αv in cancer cells is a coactivator regulated by thyroid hormone. | |
Onyx® in the management of cranial arteriovenous malformations. | |
Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model | |
Oral anticoagulants and status of antidotes for the reversal of bleeding risk. | |
Oral Contraceptive Types in Relation to ABO Blood Groups Among Saudi Women of Different Reproductive Age Groups and Impact on Venous Thromboembolism | |
Oral direct factor Xa inhibitors, with special emphasis on rivaroxaban. | |
Overlapping nongenomic and genomic actions of thyroid hormone and steroids. | |
Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases | |
Particle coatings but not silver ions mediate genotoxicity of ingested silver nanoparticles in a mouse model | |
Pharmacodynamic modeling of anti-cancer activity of tetraiodothyroacetic acid in a perfused cell culture system | |
Pharmacogenetics in breast cancer: steps toward personalized medicine in breast cancer management | |
Pharmacogenomics in thrombosis. | |
Pharmacokinetic Evaluation of Empagliflozin in Healthy Egyptian Volunteers Using LC-MS/MS and Comparison with Other Ethnic Populations | |
Pharmacokinetics, Biodistribution, and Anti-Angiogenesis Efficacy of Diamino Propane Tetraiodothyroacetic Acid-conjugated Biodegradable Polymeric Nanoparticle. | |
Pharmacotherapy in COVID 19: Potential Impact of Targeting the Complement System | |
Pomegranate (Punica granatum) Fruit Extract Suppresses Cancer Progression and Tumor Angiogenesis of Pancreatic and Colon Cancer in Chick Chorioallantoic Membrane Model | |
Possible contributions of thyroid hormone replacement to specific behaviors of cancer | |
PPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis. | |
Prasugrel: a novel platelet ADP P2Y(12) receptor antagonist. | |
Prognostic value of some inflammatory markers in patients with lymphoma | |
Protective Effects of Miswak (Salvadora persica) against Experimentally Induced Gastric Ulcers in Rats | |
Protective Roles of Thymoquinone Nanoformulations: Potential Nanonutraceuticals in Human Diseases | |
Quantification of the Healing Effect in Hepatic Fibrosis Induced by Chitosan Nano-Encapsulated Green Tea in Rat Model. | |
Quercetin Attenuates Pancreatic and Renal D-Galactose-Induced Aging-Related Oxidative Alterations in Rats | |
Recent advances in management of autosomal-dominant polycystic kidney disease. | |
Regional consensus opinion for the management of Beta thalassemia major in the Arabian Gulf area | |
Repositioning of dipeptidyl peptidase-4 inhibitors and glucagon like peptide-1 agonists as potential neuroprotective agents | |
Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent. | |
Resveratrol and Its Nanoformulation Attenuate Growth and the Angiogenesis of Xenograft and Orthotopic Colon Cancer Models | |
Riociguat for the management of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension | |
Rituximab in the treatment of idiopathic thrombocytopenic purpura (ITP). | |
Role and Mechanisms of RAGE-Ligand Complexes and RAGE-Inhibitors in Cancer Progression | |
Self-assembly of green tea catechin derivatives in nanoparticles for oral lycopene delivery | |
Semisynthesis and pharmacological activities of thyroxine analogs: Development of new angiogenesis modulators. | |
The shortcomings of clinical trials assessing the efficacy of probiotics in irritable bowel syndrome. | |
Single low-dose un-adjuvanted HBsAg nanoparticle vaccine elicits robust, durable immunity | |
Status and future directions in the management of pancreatic cancer: potential impact of nanotechnology | |
Stem cells in the management of heart failure: what have we learned from clinical trials? | |
Stress resistant human embryonic stem cells as a potential source for the identification of novel cancer stem cell markers. | |
Sulfated non-anticoagulant heparin blocks Th2-induced asthma by modulating the IL-4/signal transducer and activator of transcription 6/Janus kinase 1 pathway | |
Suppression of pancreatic cancer by sulfated non-anticoagulant low molecular weight heparin | |
Surface modification of a polyethylene film for anticoagulant and anti-microbial catheter. | |
Synthesis of a new class of furo[3,2-c]coumarins and its anticancer activity | |
Synthesis of new analogs of tetraiodothyroacetic acid (tetrac) as novel angiogenesis inhibitors for treatment of cancer. | |
Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release | |
Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac. | |
Targeting PCSK9 as a promising new mechanism for lowering low-density lipoprotein cholesterol. | |
Taribavirin and 5-Fluorouracil-Loaded Pegylated-Lipid Nanoparticle Synthesis, p38 Docking, and Antiproliferative Effects on MCF-7 Breast Cancer. | |
Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different Status | |
Tetrac downregulates β-catenin and HMGA2 to promote the effect of resveratrol in colon cancer | |
Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer. | |
Tetraiodothyroacetic acid (tetrac), integrin αvβ3 and disabling of immune checkpoint defense | |
Therapeutics formulated to target cancer stem cells: Is it in our future? | |
Thymoquinone Attenuates Cardiomyopathy in Streptozotocin-Treated Diabetic Rats | |
Thymoquinone Defeats Diabetes-Induced Testicular Damage in Rats Targeting Antioxidant, Inflammatory and Aromatase Expression | |
Thymoquinone Modulates Blood Coagulation in Vitro via Its Effects on Inflammatory and Coagulation Pathways. | |
Thyroid hormone and anti-apoptosis in tumor cells. | |
Thyroid Hormone in the Clinic and Breast Cancer. | |
Tinzaparin for Long-Term Treatment of Venous Thromboembolism in Patients With Cancer. | |
Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol: High Affinity Thyrointegrin αvβ3 Antagonist with Potent Anticancer Activities in Glioblastoma Multiforme | |
Use of recombinant activated factor VII to arrest uncontrolled bleeding: a case series. |